NCT03361878View on ClinicalTrials.gov

Pharmacokinetics of Metformin Intolerance

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 4, 2014

Primary Completion Date

May 5, 2016

Study Completion Date

May 5, 2016

Conditions
Diabetes Mellitus, Type 2Metformin Adverse Reaction
Interventions
DRUG

Metformin Hydrochloride

Single dose of 500mg oral metformin

All Listed Sponsors
collaborator

University of Southern Denmark

OTHER

collaborator

University of Dundee

OTHER

collaborator

Helmholtz Zentrum München

INDUSTRY

lead

NHS Tayside

OTHER_GOV

NCT03361878 - Pharmacokinetics of Metformin Intolerance | Biotech Hunter | Biotech Hunter